Showing 21-40 of 76 for: Cochrane Systematic Reviews > Male genitourinary 
- Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection
Cochrane Systematic Reviews, 10-Nov-2008
Embryo transfer (ET) was traditionally performed two days after oocyte retrieval; however, developments in culture media have allowed embryos to be maintained in culture for longer periods. Delaying transfer from day two to day three would allow for furth
- Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer
Cochrane Systematic Reviews, 11-Jun-2019
Standard androgen suppression therapy (AST) using surgical or medical castration is considered a mainstay of advanced hormone-sensitive prostate cancer treatment. AST can be initiated early when disease is asymptomatic or deferred when patients suffer sym
- Finasteride for benign prostatic hyperplasia
Cochrane Systematic Reviews, 17-Dec-2015
Benign prostatic hyperplasia (BPH), a non-malignant enlargement of the prostate in aging men, can cause bothersome urinary symptoms (intermittency, weak stream, straining, urgency, frequency, incomplete emptying). Finasteride, a five-alpha reductase inhib
- Gonadotrophins for idiopathic male factor subfertility
Cochrane Systematic Reviews, 18-Aug-2013
Male factors leading to subfertility account for at least half of all cases of subfertility worldwide. Although some causes of male subfertility are treatable, treatment of idiopathic male factor subfertility remains empirical. Researchers have used gonad
- Growth hormone for in vitro fertilisation (IVF)
Cochrane Systematic Reviews, 22-Nov-2021
In an effort to improve outcomes of in vitro fertilisation (IVF) cycles, the use of growth hormone (GH) has been considered as adjuvant treatment in ovarian stimulation. Improving the outcomes of IVF is especially important for women with infertility who
- In vitro fertilisation for unexplained subfertility
Cochrane Systematic Reviews, 18-Nov-2015
One-third of subfertile couples have no identifiable cause for their inability to conceive. In vitro fertilisation (IVF) is a widely accepted treatment for this condition; however, this treatment is invasive and expensive and is associated with risks.
- Intermittent versus continuous androgen suppression for prostatic cancer
Cochrane Systematic Reviews, 17-Jan-2012
After lung cancer, prostate cancer is the most common cause of death among males. The aim of treatment is to prevent disease-related morbidity and mortality while minimizing intervention-related adverse events. Androgen suppression therapy (AST) to reduce
- Interventions for chronic abacterial prostatitis
Cochrane Systematic Reviews, 3-Apr-2011
Chronic abacterial prostatitis is a common disabling but enigmatic condition with a symptom complex of pelvic area pain and lower urinary tract symptoms. The scope of treatments recommended for chronic abacterial prostatitis is a testament to how little i
- Interventions for cutaneous molluscum contagiosum
Cochrane Systematic Reviews, 9-Jun-2015
Molluscum contagiosum is a common skin infection, caused by a pox virus. The infection will usually resolve within months in people with a normal immune system. Many treatments have been used for molluscum contagiosum but a clear evidence base supporting
- Interventions for encouraging sexual behaviours intended to prevent cervical cancer
Cochrane Systematic Reviews, 27-Mar-2014
Human papillomavirus (HPV) is the key risk factor for cervical cancer. Continuing high rates of HPV and other sexually transmitted infections (STIs) in young people demonstrate the need for effective behavioural interventions.
- Interventions for sexual dysfunction following treatments for cancer in women
Cochrane Systematic Reviews, 2-Feb-2016
The proportion of people living with and surviving cancer is growing. This has led to increased awareness of the importance of quality of life, including sexual function, in those affected by cancer. Sexual dysfunction is a potential long-term complicatio
- Interventions for treating sexual dysfunction in patients with chronic kidney disease
Cochrane Systematic Reviews, 10-Nov-2010
Sexual dysfunction is very common in patients with chronic kidney disease (CKD), but it is still significantly understudied. Treatment options exist but concerns have been raised relating to their efficacy and safety in CKD.
- Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in couples with non-male subfertility
Cochrane Systematic Reviews, 12-Jun-2011
In vitro fertilisation (IVF) as treatment for male factor subfertility is associated with lower fertilisation and pregnancy rates than for other indications. Since the late 1980s several assisted fertilisation techniques have emerged and have been rapidly
- Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
Cochrane Systematic Reviews, 30-Oct-2013
Intrauterine insemination (IUI) is a common treatment for couples with subfertility that does not involve the fallopian tubes. It is used to bring the sperm close to the released oocyte. Another method of introducing sperm is fallopian tube sperm perfusio
- Intra-uterine insemination versus timed intercourse or expectant management for cervical hostility in subfertile couples
Cochrane Systematic Reviews, 20-Sep-2010
The postcoital test has poor diagnostic and prognostic characteristics. Nevertheless, some physicians believe it can identify scanty or abnormal mucus that might impair fertility. One way to avoid 'hostile' cervical mucus is intrauterine insemination. Wit
- Kinin-enhancing drugs for unexplained subfertility in men
Cochrane Systematic Reviews, 17-Jul-2008
Oligo-astheno-teratospermia (sperm of low concentration, reduced motility and increased abnormal morphology) of unknown cause is common and the need for treatment is felt by patients and doctors alike. As a result, a variety of empirical, non-specific tre
- Laser prostatectomy for benign prostatic obstruction
Cochrane Systematic Reviews, 9-Nov-2008
Symptomatic benign prostatic obstruction is a common problem for older men. The gold standard treatment, transurethral resection of the prostate (TURP), significantly improves urinary symptoms and urinary flow. However, TURP has up to a 20% morbidity. Cur
- Lidocaine-prilocaine cream for analgesia during circumcision in newborn boys
Cochrane Systematic Reviews, 3-Apr-2015
Neonates routinely undergo tissue-damaging interventions as part of medical treatment. The skin is the site of noxious stimulation for many procedures, including circumcision. EMLA (eutectic mixture of local anesthetics) penetrates intact skin and has the
- Low-dose rate brachytherapy for men with localized prostate cancer
Cochrane Systematic Reviews, 26-May-2011
Localized prostate cancer is a slow growing tumor for many years for the majority of affected men. Low-dose rate brachytherapy (LDR-BT) is short-distance radiotherapy using low-energy radioactive sources. LDR-BT has been recommended for men with low risk
- Male circumcision for prevention of heterosexual acquisition of HIV in men
Cochrane Systematic Reviews, 30-Apr-2013
Male circumcision is defined as the surgical removal of all or part of the foreskin of the penis and may be practiced as part of a religious ritual, as a medical procedure, or as part of a traditional ritual performed as an initiation into manhood. Since
